Abbott Laboratories Q3 2026 Results: Net Income $920M, Down 44.0% YoY
Abbott Laboratories completed the $20.6 billion acquisition of Exact Sciences in March 2026, significantly expanding its cancer diagnostics portfolio. The company reported net earnings allocated to common shares of $2.9 billion for the first nine months of 2026, while managing a contract liability balance of $669 million and a goodwill increase to $32.6 billion.
- Key figure
- Net income $920M · -44.0% YoY